![Sample size estimation for clinical trials in de novo Parkinson's disease (PD): Results from the Parkinson's Progression Markers Initiative (PPMI) Study - MDS Abstracts Sample size estimation for clinical trials in de novo Parkinson's disease (PD): Results from the Parkinson's Progression Markers Initiative (PPMI) Study - MDS Abstracts](https://www.mdsabstracts.org/wp-content/uploads/2017/05/0037-002207_001.png)
Sample size estimation for clinical trials in de novo Parkinson's disease (PD): Results from the Parkinson's Progression Markers Initiative (PPMI) Study - MDS Abstracts
![Pharmaceuticals | Free Full-Text | Current Therapies in Clinical Trials of Parkinson's Disease: A 2021 Update | HTML Pharmaceuticals | Free Full-Text | Current Therapies in Clinical Trials of Parkinson's Disease: A 2021 Update | HTML](https://www.mdpi.com/pharmaceuticals/pharmaceuticals-14-00717/article_deploy/html/images/pharmaceuticals-14-00717-g002.png)
Pharmaceuticals | Free Full-Text | Current Therapies in Clinical Trials of Parkinson's Disease: A 2021 Update | HTML
![Parkinson's Disease: Current and Future Therapeutics and Clinical Trials: Galvez-Jimenez, Nestor: 9781107053861: Books Parkinson's Disease: Current and Future Therapeutics and Clinical Trials: Galvez-Jimenez, Nestor: 9781107053861: Books](https://images-na.ssl-images-amazon.com/images/I/511KCrQzxML._SX391_BO1,204,203,200_.jpg)
Parkinson's Disease: Current and Future Therapeutics and Clinical Trials: Galvez-Jimenez, Nestor: 9781107053861: Books
![Neurotrophic factors for disease-modifying treatments of Parkinson's disease: gaps between basic science and clinical studies | SpringerLink Neurotrophic factors for disease-modifying treatments of Parkinson's disease: gaps between basic science and clinical studies | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs43440-020-00120-3/MediaObjects/43440_2020_120_Fig1_HTML.png)
Neurotrophic factors for disease-modifying treatments of Parkinson's disease: gaps between basic science and clinical studies | SpringerLink
![NIH launches partnership to improve success of clinical trials for patients with Parkinson's disease | National Institutes of Health (NIH) NIH launches partnership to improve success of clinical trials for patients with Parkinson's disease | National Institutes of Health (NIH)](https://www.nih.gov/sites/default/files/styles/featured_media_breakpoint-medium/public/research-training/initiatives/amp/AMP-parkinsons.png?itok=8YS_wgIE×tamp=1517237384)
NIH launches partnership to improve success of clinical trials for patients with Parkinson's disease | National Institutes of Health (NIH)
![Upcoming Clinical Trial Will Test New Cell Therapy for Parkinson's Disease in Humans | Memorial Sloan Kettering Cancer Center Upcoming Clinical Trial Will Test New Cell Therapy for Parkinson's Disease in Humans | Memorial Sloan Kettering Cancer Center](https://www.mskcc.org/sites/default/files/styles/large/public/node/216883/3x2/studer-and-tabar.jpg)
Upcoming Clinical Trial Will Test New Cell Therapy for Parkinson's Disease in Humans | Memorial Sloan Kettering Cancer Center
![Effectiveness of home-based and remotely supervised aerobic exercise in Parkinson's disease: a double-blind, randomised controlled trial - The Lancet Neurology Effectiveness of home-based and remotely supervised aerobic exercise in Parkinson's disease: a double-blind, randomised controlled trial - The Lancet Neurology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/3ece7627-d329-4a3e-8c88-986f5ea97a3e/gr1.gif)